The China Pharmaceutical Guidebook Series are the essential resources of the latest Chinese regulations for imported drug registration. This new guidebook series guide overseas pharmaceutical manufacturers and producers step by step to achieve a successful application and approval for their imported drug registration to enter a lucrative drug market in China. This guidebook series are composed of four guidebooks as the following.
Latest Chinese Regulations for Imported Drug Registration:
Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration:
Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration:
Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration:
In this guidebook series, overseas pharmaceutical manufacturers and producers can easily find out every answer that they will meet question during process of application and approval for their imported drug registration.
This is the second guidebook of the China Pharmaceutical Guidebook Series. It provided a detailed introduction of the Chinese pharmaceutical authority’s requirements for materials and clinical trials of registration application for imported chemical drugs, including radioactive pharmaceuticals.
Scope of the Report
An overview of the classification of drug registration formulated by the SFDA (The State Food and Drug Administration in China).
The material items for application of drug registration.
The requirements of material items for application of drug registration.
The requirements of clinical trial for application of drug registration.
The material and clinical trial requirements for application of radioactive pharmaceuticals
The significant suggestions for overseas pharmaceutical manufacturers and producers looking to achieve a successful application for their chemical drug registration in China
For more information, Please visit :
http://www.bharatbook.com/
